Abbott Introduces the Lingo Over-The-Counter Continuous Glucose Monitor in the US Market
Overview of Abbott's Lingo CGM
Abbott has officially launched its Lingo over-the-counter continuous glucose monitor (CGM) in the United States. This innovative device is priced at a competitive rate of $49 for a single 14-day sensor or $89 on a monthly subscription basis.
Comparative Analysis with Competitors
The Lingo CGM offers a compelling alternative in the growing market for continuous glucose monitoring technologies. When compared to Dexcom's Stelo sensor, Abbott's approach emphasizes affordability while prioritizing user-friendly features.
Impact on Diabetes Management
- The Lingo CGM enhances accessibility for individuals managing diabetes.
- Cost-benefit analysis shows potential savings for users.
- Provides a critical tool for real-time glucose monitoring.
The introduction of Abbott's Lingo CGM could signify a transformative leap in how diabetes management is approached, making monitoring more accessible and affordable.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.